Australia's most trusted
source of pharma news
Posted 7 October 2022 PM
German powerhouse BioNTech has signed an in-principle partnership with the Victorian State Government to establish an Asia Pacific mRNA clinical research and development centre in Melbourne.
The facility will form part of BioNTech's global network and according to the government will see the company deliver next-generation mRNA therapeutics and vaccines for research and clinical trials - including infectious diseases, cancer medicines and personalised cancer treatments.
The biotech has become a household name after its collaboration with Pfizer to develop the mega blockbuster mRNA Covid vaccine Comirnaty.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.